Michael Franken - Net Worth and Insider Trading
Michael Franken Net Worth
The estimated net worth of Michael Franken is at least $2 Million dollars as of 2024-04-27. Michael Franken is the President, Biosimilars Busines of Momenta Pharmaceuticals Inc and owns about 37,968 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $2 Million. Details can be seen in Michael Franken's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Franken has not made any transactions after 2015-12-11 and currently still holds the listed stock(s).
Transaction Summary of Michael Franken
Michael Franken Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Franken owns 2 companies in total, including Momenta Pharmaceuticals Inc (MNTA) , and Radius Health Inc (RDUS) .
Click here to see the complete history of Michael Franken’s form 4 insider trades.
Insider Ownership Summary of Michael Franken
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNTA | Momenta Pharmaceuticals Inc | 2015-12-11 | President & Biosimilars Busines |
| RDUS | Radius Health Inc | 2012-04-11 | Sr. V.P. & Chief Bus. Officer |
Michael Franken Latest Holdings Summary
Michael Franken currently owns a total of 1 stock. Michael Franken owns 37,968 shares of Momenta Pharmaceuticals Inc (MNTA) as of December 11, 2015, with a value of $2 Million.
Latest Holdings of Michael Franken
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MNTA | Momenta Pharmaceuticals Inc | 2015-12-11 | 37,968 | 52.48 | 1,992,561 |
Holding Weightings of Michael Franken
Michael Franken Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Franken has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 520 shares on December 11, 2015, which brought Michael Franken around $8,237.
Insider Trading History of Michael Franken
- 1
Michael Franken Trading Performance
Michael Franken Ownership Network
Ownership Network List of Michael Franken
Ownership Network Relation of Michael Franken
Michael Franken Owned Company Details
What does Momenta Pharmaceuticals Inc do?
Who are the key executives at Momenta Pharmaceuticals Inc?
Michael Franken is the President & Biosimilars Busines of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief HR and Inf. Officer Jo Ann Beltramello , Chief Scientific Officer Anthony M. Manning , and Chief Legal Officer Alejandra Carvajal .
Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Momenta Pharmaceuticals Inc Insider Transactions
Michael Franken Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Franken. You might contact Michael Franken via mailing address: C/o Radius Health, Inc. 201 Broadway, 6th Floor Boston Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
